{
  "docId": "019de074-248c-77af-a5ab-b494f367e40c",
  "docSlug": "04e7658d1ef5dbf257df69b08c2ecb71",
  "documentTitle": "Absci | Investor Conference Presentation Deck | 21 slides",
  "authorId": "absci",
  "authorName": null,
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 14,
  "pageCount": 21,
  "prevPage": 13,
  "nextPage": 15,
  "slideType": "before_after",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 100,
  "notes": "The chart shows a dot plot of Naturalness vs Sequence Diversity, with a red dashed line indicating the Wildtype baseline.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-248c-77af-a5ab-b494f367e40c/14",
  "deckHref": "/decks/019de074-248c-77af-a5ab-b494f367e40c",
  "deckJsonHref": "/decks/019de074-248c-77af-a5ab-b494f367e40c.json",
  "deckAnchorHref": "/decks/019de074-248c-77af-a5ab-b494f367e40c#slide-14",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.5,
        "y": 0.3
      },
      "kind": "chart",
      "text": "Naturalness vs Sequence Diversity dot plot",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0374e7f4-024c-4290-a62b-0a79f2b1c753",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.04,
        "y": 0.33
      },
      "kind": "list",
      "text": "Better therapeutics, faster: Successfully designed antibody variants with higher Naturalness score; The Naturalness score is associated with developability metrics such as immunogenicity. Model is validated and broadly applicable: Successfully demonstrated across four therapeutic targets: HER2, VEGF-A, COVID omicron, undisclosed target.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fde432e5-8524-4592-b420-be365b79e8c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.04,
        "y": 0.1
      },
      "kind": "title",
      "text": "AI model is broadly applicable enabling higher potential therapeutics",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df53dbf0-8513-43a4-9e13-14aee34e36ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "Case Study: de novo Discovery in silico",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "afcc0f1d-e528-4194-9331-b74f10062fb1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 16,
      "from": 14,
      "beatId": "fb27d116-e18f-49d5-bf20-8ef3e3075b92",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Desire",
      "beatSlug": "aida-desire",
      "evidence": "Slides 14-16 highlight the potential impact and value drivers of Absci's platform",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}